Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Yachmetz Philip K
Relationship:   Co-President and CBO
City:   Wyckoff
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   98,241    

Indirect Shares

   200      
Direct Value   $31,554    

Indirect Value

   $820      
Total Shares   98,441      
Total Value   $32,374      


Progenics Pharmaceuticals Inc $31,554 Savient Pharmaceuticals Inc $0 Progenics Pharmaceuticals Inc $31,554 Savient Pharmaceuticals Inc $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progenics Pharmaceuticals Inc PGNX VP, General Counsel 2004-05-03 7,696 2004-05-03 200    Premium*  
            Savient Pharmaceuticals Inc SVNTQ Co-President and CBO 2013-10-15 90,545 2004-06-04 0    Premium*  
* Premium Members only  

Records found :    53         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-07 4 OE $2.42 $13,450 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-08 4 OE $2.42 $12,100 D/D 5,000 148,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-01-08 4 S $23.15 $115,760 D/D (5,000) 143,087 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-02-15 4 AS $20.01 $47,233 D/D (2,361) 140,726 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-02-20 4 AS $20.01 $49,113 D/D (2,455) 138,271 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-03-05 4 D $23.49 $221,406 D/D (9,425) 149,596 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-03-05 4 A $23.01 $477,458 D/D 20,750 159,021 0 -
SVNTQ Savient Pharmaceuticals I... EVP, Chief Business Officer   •       –      –    2008-04-14 4 AS $19.00 $71,919 D/D (3,785) 145,811 0 -
SVNTQ Savient Pharmaceuticals I... EVP - Chief Business Officer   •       –      –    2008-11-04 4 D $5.17 $52,837 D/D (10,220) 158,091 0 -
SVNTQ Savient Pharmaceuticals I... EVP - Chief Business Officer   •       –      –    2008-11-04 4 A $5.17 $116,325 D/D 22,500 168,311 0 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2008-12-08 4 A $4.53 $67,950 D/D 15,000 173,091 0 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2008-12-09 4 AS $4.86 $31,104 D/D (6,400) 166,691 0 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2009-02-13 4/A A $5.94 $148,500 D/D 25,000 191,691 0 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2009-02-13 4 A $5.94 $148,500 D/D 25,000 191,691 0 -
SVNTQ Savient Pharmaceuticals I... SVP - General Counsel   •       –      –    2009-02-17 4 AS $5.73 $33,635 D/D (5,868) 185,823 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2009-09-14 4 S $15.75 $59,063 D/D (3,750) 182,073 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2009-09-15 4 S $16.25 $60,938 D/D (3,750) 178,323 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2009-12-09 4 AS $13.31 $72,118 D/D (5,418) 172,905 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2010-02-16 4 AS $13.79 $79,706 D/D (5,778) 167,127 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2010-09-16 4 D $20.27 $164,552 D/D (8,118) 185,234 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2010-09-16 4 A $20.27 $464,548 D/D 22,918 193,352 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2011-02-14 4 AS $9.88 $31,724 D/D (3,210) 182,024 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2011-09-16 4 B $4.13 $28,910 D/D 7,000 189,024 2.74 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2012-02-01 4 A $2.26 $113,000 D/D 50,000 239,024 0 -
SVNTQ Savient Pharmaceuticals I... SVP, General Counsel   •       –      –    2012-02-14 4 AS $2.02 $7,151 D/D (3,540) 235,484 0 -
  53  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us